Transmyocardial laser revascularization increases dobutamine-induced angina threshold in patients with refractory angina

Transmyocardial Revascularization Transmyocardial Revascularization With CO2 Laser in Patients With Refractory Angina Pectoris Clinical Results from The Norwegian Randomized Trial

RESULTS Transmyocardial laser revascularization resulted in significant relief in angina symptoms after three and 12 months compared to baseline. Time to chest pain during exercise increased from baseline by 78 s after three months (p 5 NS) and 66 s (p , 0.01) after 12 months in the TMR group, whereas total exercise time and MVO2 were unchanged. No significant changes were observed in the MT gr...

Intermediate-term clinical outcome following transmyocardial laser revascularization in patients with refractory angina pectoris.

BACKGROUND This study was conducted to examine the intermediate-term clinical outcomes in patients with refractory angina pectoris treated with transmyocardial laser revascularization (TMR) at our institution. TMR is an alternative surgical technique for the treatment of myocardial ischemia and angina pectoris not amenable to conventional percutaneous or surgical revascularization. Limited data...

The Heart Laser(TM): transmyocardial revascularization treatment of angina pectoris.

Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris. Clinical results from the Norwegian randomized trial.

OBJECTIVES The purpose of the study was to evaluate clinical effects, exercise performance and effect on maximal oxygen consumption (MVO2) of transmyocardial revascularization with CO2-laser (TMR) in patients with refractory angina pectoris. BACKGROUND Transmyocardial laser revascularization is a new method to treat patients with refractory angina pectoris not eligible for conventional revasc...

[Cell therapy plus transmyocardial laser revascularization: a proposed alternative procedure for refractory angina].

OBJECTIVE We tested the hypothesis that TMLR combined with intramyocardial injection of BMC is safe, and may help increase the functional capacity of patient with refractory angina. METHODS Nine patients (eight men), 65+/-5 years old, with refractory angina for multivessel disease and previous myocardial revascularization procedures (CABG/PCI), not candidates for another procedure due to the ...